INS and Insulin resistance: Indeed, PKC’s purported role in dysregulating insulin signalling through inhibition of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway may suggest a role for sphingosine in ameliorating cellular insulin resistance phenotypes [57].